Isolation and characterization of bacteriophages of theBurkholderia cepaciacomplex

Butler, 1995, Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard, J. Clin. Microbiol., 33, 1001, 10.1128/JCM.33.4.1001-1004.1995

Govan, 1996, Burkholderia cepacia: medical, taxonomic, and ecological issues, J. Med. Microbiol., 45, 395, 10.1099/00222615-45-6-395

Mahenthiralingam, 2002, Burkholderia cepacia complex infection in patients with cystic fibrosis, J. Med. Microbiol., 51, 533, 10.1099/0022-1317-51-7-533

Mahenthiralingam, 2005, The multifarious, multireplicon Burkholderia cepacia complex, Nat. Rev. Microbiol., 3, 144, 10.1038/nrmicro1085

Coenye, 2001, Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex comprising biocontrol and cystic-fibrosis related isolates, Int. J. Syst. Evol. Microbiol., 51, 1481, 10.1099/00207713-51-4-1481

Coenye, 2001, Taxonomy and identification of the Burkholderia cepacia complex, J. Clin. Microbiol., 39, 3427, 10.1128/JCM.39.10.3427-3436.2001

Vandamme, 1997, Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov, Int. J. Syst. Bacteriol., 47, 1188, 10.1099/00207713-47-4-1188

Vandamme, 2000, Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV), J. Clin. Microbiol., 38, 1042, 10.1128/JCM.38.3.1042-1047.2000

Vandamme, 2003, Burkholderia cenocepacia sp. nov. – a new twist to an old story, Res. Microbiol., 154, 91, 10.1016/S0923-2508(03)00026-3

Vermis, 2004, Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov, Int. J. Syst. Evol. Microbiol., 54, 689, 10.1099/ijs.0.02888-0

Speert, 2002, Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis in Canada: geographical distribution and clustering of strains, Emerg. Infect. Dis., 8, 181, 10.3201/eid0802.010163

LiPuma, 2002, An epidemic Burkholderia cepacia complex strain identified in soil, Lancet, 359, 2002, 10.1016/S0140-6736(02)08836-0

Isles, 1984, Pseudomonas cepacia infection in cystic fibrosis: an emerging problem, J. Pediatr., 104, 206, 10.1016/S0022-3476(84)80993-2

Liou, 2001, Predictive 5-years survivorship model of cystic fibrosis, Am. J. Epidemiol., 153, 345, 10.1093/aje/153.4.345

Aaron, 2000, Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia, Am. J. Respir. Crit. Care Med., 161, 1206, 10.1164/ajrccm.161.4.9907147

LiPuma, 2001, Disproportionate distribution of B. cepacia complex species and transmissibility markers in cystic fibrosis, Am. J. Respir. Crit. Care Med., 164, 92, 10.1164/ajrccm.164.1.2011153

Speert, 2001, Understanding Burkholderia cepacia: epidemiology, genomovars, and virulence, Infect. Med., 18, 49

Chaparro, 2001, Infection with Burkholderia cepacia in cystic fibrosis. Outcome following lung transplantation, Am. J. Respir. Care Med., 163, 43, 10.1164/ajrccm.163.1.9811076

Soya, 2004, Prevalence and clonality in UK patients with cystic fibrosis referred for lung transplantation, Thorax, 59, 526, 10.1136/thx.2003.010801

Biddick, 2003, Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans, and Burkholderia dolosa among persons with cystic fibrosis, FEMS Microbiol. Lett., 228, 57, 10.1016/S0378-1097(03)00724-9

Burns, 1996, Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance, Antimicrob. Agents Chemother., 40, 307, 10.1128/AAC.40.2.307

Hancock, 1997, Peptide antibiotics, Lancet, 349, 418, 10.1016/S0140-6736(97)80051-7

Merril, 2003, The prospect for bacteriophage therapy in Western medicine, Nat. Rev. Drug Discov., 2, 489, 10.1038/nrd1111

Biswas, 2002, Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium, Infect. Immun., 70, 204, 10.1128/IAI.70.1.204-210.2002

Matsuzaki, 2003, Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11, J. Infect. Dis., 187, 613, 10.1086/374001

Wills, 2005, Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model, Antimicrob. Agents Chemother., 49, 1220, 10.1128/AAC.49.3.1220-1221.2005

Matsumoto, 1986, A generalized transducing phage of Pseudomonas cepacia, J. Gen. Microbiol., 132, 2583

Cihlar, 1978, Characterization of bacteriophage CP1, an organic solvent sensitive phage associated with Pseudomonas cepacia, Can. J. Microbiol., 24, 1404, 10.1139/m78-224

Nzula, 2000, Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages, FEMS Immunol. Med. Microbiol., 28, 307, 10.1111/j.1574-695X.2000.tb01491.x

Langley, 2003, Lysogeny and bacteriophage host range within the Burkholderia cepacia complex, J. Med. Microbiol., 52, 483, 10.1099/jmm.0.05099-0

Summer, 2004, Burkholderia cenocepacia phage BcepMu and a family of Mu-like phages encoding potential pathogenesis factors, J. Mol. Biol., 340, 49, 10.1016/j.jmb.2004.04.053

Lipuma, 2000, Isolation of soil-borne genomovar III Burkholderia cepacia and lytic phages with interspecies host range, Pediatr. Pulmonol., S20, 288

Mahenthiralingam, 2000, Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex, J. Clin. Microbiol., 38, 910, 10.1128/JCM.38.2.910-913.2000

Coenye, 2003, Updated version of the Burkholderia cepacia complex experimental strain panel, J. Clin. Microbiol., 41, 2797, 10.1128/JCM.41.6.2797-2798.2003

[35] Sambrook, J., Fritsch, E.F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

Altschul, 1990, Basic local alignment search tool, J. Mol. Biol., 215, 403, 10.1016/S0022-2836(05)80360-2

Burkholder, 1950, Sour skin, a bacterial rot of onion bulbs, Phytopathology, 40, 115

Parke, 2001, Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains, Annu. Rev. Phytopathol., 39, 225, 10.1146/annurev.phyto.39.1.225

Woods, 2002, Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei, J. Bacteriol., 184, 4003, 10.1128/JB.184.14.4003-4017.2002

DeShazer, 2004, Genomic diversity of Burkholderia pseudomallei clinical isolates: subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b, J. Bacteriol., 186, 3938, 10.1128/JB.186.12.3938-3950.2004